Possible Content of the Tele-Conference or Phone talk

1. First Section: Securing Informed Consent: (Know your options)

In the first Section of the tele-conference conversation, we usually give the caller (caretaker or patient-student-coachee) the Institute’s impressions with regard to the strengths and weaknesses of different conventional cancer options, in particular the one or ones the consultee is interested in.

Thereafter, we will do the same with integrative and holistic oncology.

Upon request, we will email the references. We will also tell the consultee what the Research has determined the cancer’s natural course to be. (1)

Lastly, we will analyze with the patient-student and-or caretaker the pending clinical trials that concern the cancer the consultee is interested in, and determine which ones look the most promising and adapted to the cancer under consideration. In this way, the patient will know all or most of the relevant and credible options for his or her diagnosis.

Most conventional and integrative oncologists don’t secure informed consent, preferring to quickly sell their speciality.

Without speaking about all published credible options, these doctors violate an important obligation in the practice of medicine.

Unless the patient is a minor, the adult patient always has an absolute right to consent or not to consent with regard to a proposed treatment plan.

Too many doctors use scare tactics, manipulation or corporate charm to get the patient to consent to their profit-making protocol. We will also briefly guide the patient with what types of questions the patient should ask both his primary doctor and his oncology team.

2. Second Section: Holistic Oncology

In the second Section of the Initiation Consultation, we will explain what Holistic oncology is and how it differs from integrative and conventional oncology.

Thereafter, we will determine if the cancer under consideration could favorably respond to Holistic Oncology as a stand-alone or in combination with conventional and-or integrative oncology.

Once this determination is made, we will talk about different possible therapeutic strategies and treatment plans, most of which are supported by strong Science.

And lastly, we will share what Science has determine to be the best cancer diagnostic and monitoring tests, in this way, whatever the patient chooses for an option, she or he will be able to evaluate if the treatment plan is safe and efficient.

3. Miscellaneous Questions

The above-mentioned topics should cover most of the Initiation Consultation, from 90 minutes to two hours.

This content should give the consultee enough information to make an informed decision on what matters, what to do and what not to do, thereby saving not only huge amounts of money, but also body parts and possibly one’s life.

If the patient-student or caretaker wishes to ask other questions, we will do our best to answer them within the allotted time, ie, up to two hours.

Reference

(1). Each diseases have a “natural course”. Many bacterial and viral infections for example builds a fever, produces different symptoms like sweating, weakness and head-aches and then go away on its own thanks to the immune system’s mobilization. Some diagnosed early cancers are characterized as “indolent” and even though they have been biopsied as malignant cancers, many of these cancers will go away on their own. This is the case of certain endocrine cancers like breast carcinoma in situ and prostate cancer. (Link). To a lesser degree, also with thyroid cancer (Link). However, once the cancer has vascularized significantly and-or metastasized or shed some of its cancer stem cells into the bloodstream, then the natural course tends to be the development of new tumors that colonize different bodily tissues,  with an array of concomitant symptoms. This is called micro-metastases, the end-stage phase most cancer patients die from. Yet, Conventional oncology does not invest much research in this field, preferring to invest in the destruction of symptoms like primary tumors and their affected nodes and  proximate zones.

Screen Shot 2015-04-24 at 5.34.39 PM

DISCLAIMER. Nothing in this blog-webstie is to be construed as medical or legal advise, including, but not limited to replies, comments and posts, all of which can not be deemed to constitute either a therapist-patient nor an attorney-client relationship.  For additional details about privacy policy & terms of use, please see the Institute’s legal link.
2019 (c). Advanced Cancer Research Institute and agents. All rights reserved